FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Arch Venture Fund VII LP
2. Issuer Name and Ticker or Trading Symbol

Pulmatrix, Inc. [ PULM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
_____ Officer (give title below)      __ X __ Other (specify below)
Former 10% Owner
(Last)          (First)          (Middle)

8755 W HIGGINS ROAD, SUITE 1025, 
3. Date of Earliest Transaction (MM/DD/YYYY)

4/3/2018
(Street)

CHICAGO, IL 60631
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
As a result of the closing of the issuer's public offering of units consisting of common stock, Series A warrants and Series B warrants on April 3, 2018, the reporting persons ceased to beneficially own more than 10% of the issuer's common stock. Accordingly, the reporting persons are no longer subject to Section 16 in connection with their transactions in the equity securities of the issuer and will no longer report any such transactions on Form 4 or Form 5.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Arch Venture Fund VII LP
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner
ARCH Venture Partners VII, L.P.
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner
ARCH Venture Partners VII, LLC
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner
CRANDELL KEITH
C/O ARCH VENTURE FUND VII
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner
BYBEE CLINTON
C/O ARCH VENTURE FUND VII
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner
NELSEN ROBERT
C/O ARCH VENTURE FUND VII
8755 W HIGGINS ROAD, SUITE 1025
CHICAGO, IL 60631



Former 10% Owner

Signatures
/s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director of the general partner of the general partner of ARCH Venture Fund VII, L.P. 4/12/2018
** Signature of Reporting Person Date

/s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director of the general partner of ARCH Venture Partners VII, L.P. 4/12/2018
** Signature of Reporting Person Date

/s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director of ARCH Venture Partners VII, LLC 4/12/2018
** Signature of Reporting Person Date

/s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell 4/12/2018
** Signature of Reporting Person Date

/s/ Mark McDonnell, as Attorney-in-Fact for Clinton Bybee 4/12/2018
** Signature of Reporting Person Date

/s/ Mark McDonnell, as Attorney-in-Fact for Robert Nelsen 4/12/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Pulmatrix (NASDAQ:PULM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Pulmatrix Charts.
Pulmatrix (NASDAQ:PULM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Pulmatrix Charts.